nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—ALB—lung cancer	0.126	0.512	CbGaD
Olanzapine—ABCB1—lung cancer	0.12	0.488	CbGaD
Olanzapine—ORM1—Gefitinib—lung cancer	0.0718	0.133	CbGbCtD
Olanzapine—ORM1—Erlotinib—lung cancer	0.0424	0.0788	CbGbCtD
Olanzapine—ALB—Gefitinib—lung cancer	0.0302	0.0561	CbGbCtD
Olanzapine—CYP2C19—Gefitinib—lung cancer	0.0196	0.0364	CbGbCtD
Olanzapine—CYP2C19—Teniposide—lung cancer	0.019	0.0353	CbGbCtD
Olanzapine—ALB—Erlotinib—lung cancer	0.0179	0.0332	CbGbCtD
Olanzapine—ABCB1—Topotecan—lung cancer	0.0173	0.0321	CbGbCtD
Olanzapine—CYP2C9—Gefitinib—lung cancer	0.0163	0.0302	CbGbCtD
Olanzapine—ALB—Irinotecan—lung cancer	0.0161	0.03	CbGbCtD
Olanzapine—ABCB1—Gefitinib—lung cancer	0.0158	0.0293	CbGbCtD
Olanzapine—CYP2C9—Teniposide—lung cancer	0.0158	0.0293	CbGbCtD
Olanzapine—CYP2D6—Gefitinib—lung cancer	0.0149	0.0276	CbGbCtD
Olanzapine—ABCB1—Vinorelbine—lung cancer	0.0122	0.0226	CbGbCtD
Olanzapine—CYP2D6—Vinorelbine—lung cancer	0.0115	0.0213	CbGbCtD
Olanzapine—CYP1A2—Erlotinib—lung cancer	0.0107	0.0198	CbGbCtD
Olanzapine—CYP3A4—Topotecan—lung cancer	0.0104	0.0192	CbGbCtD
Olanzapine—ABCB1—Crizotinib—lung cancer	0.00968	0.018	CbGbCtD
Olanzapine—CYP3A4—Gefitinib—lung cancer	0.00947	0.0176	CbGbCtD
Olanzapine—ABCB1—Gemcitabine—lung cancer	0.00947	0.0176	CbGbCtD
Olanzapine—ABCB1—Erlotinib—lung cancer	0.00934	0.0173	CbGbCtD
Olanzapine—CYP3A4—Teniposide—lung cancer	0.00918	0.017	CbGbCtD
Olanzapine—CYP2C9—Paclitaxel—lung cancer	0.00881	0.0164	CbGbCtD
Olanzapine—CYP2D6—Erlotinib—lung cancer	0.0088	0.0163	CbGbCtD
Olanzapine—ABCB1—Paclitaxel—lung cancer	0.00855	0.0159	CbGbCtD
Olanzapine—ALB—Methotrexate—lung cancer	0.00854	0.0158	CbGbCtD
Olanzapine—ABCB1—Irinotecan—lung cancer	0.00844	0.0157	CbGbCtD
Olanzapine—CYP1A2—Etoposide—lung cancer	0.00773	0.0144	CbGbCtD
Olanzapine—ABCB1—Vinblastine—lung cancer	0.0075	0.0139	CbGbCtD
Olanzapine—CYP3A4—Vinorelbine—lung cancer	0.00729	0.0135	CbGbCtD
Olanzapine—CYP2C9—Cisplatin—lung cancer	0.00709	0.0132	CbGbCtD
Olanzapine—CYP2D6—Vinblastine—lung cancer	0.00707	0.0131	CbGbCtD
Olanzapine—HTR2A—phrenic nerve—lung cancer	0.00697	0.142	CbGeAlD
Olanzapine—ABCB1—Cisplatin—lung cancer	0.00688	0.0128	CbGbCtD
Olanzapine—ABCB1—Etoposide—lung cancer	0.00676	0.0125	CbGbCtD
Olanzapine—ABCB1—Docetaxel—lung cancer	0.00618	0.0115	CbGbCtD
Olanzapine—CYP3A4—Crizotinib—lung cancer	0.0058	0.0108	CbGbCtD
Olanzapine—CYP3A4—Erlotinib—lung cancer	0.0056	0.0104	CbGbCtD
Olanzapine—CYP3A4—Paclitaxel—lung cancer	0.00512	0.00951	CbGbCtD
Olanzapine—CYP3A4—Irinotecan—lung cancer	0.00505	0.00939	CbGbCtD
Olanzapine—ABCB1—Doxorubicin—lung cancer	0.00461	0.00856	CbGbCtD
Olanzapine—CYP3A4—Vinblastine—lung cancer	0.00449	0.00835	CbGbCtD
Olanzapine—ABCB1—Methotrexate—lung cancer	0.00446	0.00829	CbGbCtD
Olanzapine—CYP2D6—Doxorubicin—lung cancer	0.00434	0.00806	CbGbCtD
Olanzapine—HTR7—pulmonary artery—lung cancer	0.00406	0.0829	CbGeAlD
Olanzapine—CYP3A4—Etoposide—lung cancer	0.00405	0.00752	CbGbCtD
Olanzapine—CYP3A4—Docetaxel—lung cancer	0.0037	0.00688	CbGbCtD
Olanzapine—CYP3A4—Doxorubicin—lung cancer	0.00276	0.00513	CbGbCtD
Olanzapine—HTR2A—pulmonary artery—lung cancer	0.00253	0.0517	CbGeAlD
Olanzapine—HRH4—bone marrow—lung cancer	0.00187	0.0383	CbGeAlD
Olanzapine—H1F0—mammary gland—lung cancer	0.00166	0.0339	CbGeAlD
Olanzapine—FMO3—respiratory system—lung cancer	0.00151	0.0308	CbGeAlD
Olanzapine—ALB—mammary gland—lung cancer	0.00124	0.0254	CbGeAlD
Olanzapine—FMO3—bronchus—lung cancer	0.00124	0.0254	CbGeAlD
Olanzapine—H1F0—respiratory system—lung cancer	0.00111	0.0226	CbGeAlD
Olanzapine—CHRM5—epithelium—lung cancer	0.00107	0.0219	CbGeAlD
Olanzapine—HTR3A—respiratory system—lung cancer	0.00105	0.0215	CbGeAlD
Olanzapine—HRH2—cardiac atrium—lung cancer	0.000931	0.019	CbGeAlD
Olanzapine—H1F0—bronchus—lung cancer	0.00091	0.0186	CbGeAlD
Olanzapine—H1F0—trachea—lung cancer	0.000817	0.0167	CbGeAlD
Olanzapine—FMO3—lung—lung cancer	0.0008	0.0164	CbGeAlD
Olanzapine—CYP2C9—mammary gland—lung cancer	0.000775	0.0158	CbGeAlD
Olanzapine—H1F0—cardiac atrium—lung cancer	0.000767	0.0157	CbGeAlD
Olanzapine—HRH2—lung—lung cancer	0.000712	0.0146	CbGeAlD
Olanzapine—HTR7—respiratory system—lung cancer	0.000682	0.0139	CbGeAlD
Olanzapine—H1F0—bone marrow—lung cancer	0.000648	0.0132	CbGeAlD
Olanzapine—DRD2—respiratory system—lung cancer	0.000645	0.0132	CbGeAlD
Olanzapine—CHRM1—trachea—lung cancer	0.000592	0.0121	CbGeAlD
Olanzapine—H1F0—lung—lung cancer	0.000587	0.012	CbGeAlD
Olanzapine—HTR7—epithelium—lung cancer	0.00057	0.0117	CbGeAlD
Olanzapine—HTR3A—lung—lung cancer	0.00056	0.0114	CbGeAlD
Olanzapine—ORM1—bone marrow—lung cancer	0.000553	0.0113	CbGeAlD
Olanzapine—ADRA1A—epithelium—lung cancer	0.00055	0.0112	CbGeAlD
Olanzapine—FMO3—lymph node—lung cancer	0.000547	0.0112	CbGeAlD
Olanzapine—CYP1A2—respiratory system—lung cancer	0.000544	0.0111	CbGeAlD
Olanzapine—ADRA2C—bronchus—lung cancer	0.000516	0.0105	CbGeAlD
Olanzapine—HRH1—respiratory system—lung cancer	0.000509	0.0104	CbGeAlD
Olanzapine—HTR7—trachea—lung cancer	0.000504	0.0103	CbGeAlD
Olanzapine—ORM1—lung—lung cancer	0.000501	0.0102	CbGeAlD
Olanzapine—HRH2—lymph node—lung cancer	0.000487	0.00996	CbGeAlD
Olanzapine—ADRA2C—trachea—lung cancer	0.000463	0.00947	CbGeAlD
Olanzapine—ADRA2C—cardiac atrium—lung cancer	0.000435	0.0089	CbGeAlD
Olanzapine—HRH1—epithelium—lung cancer	0.000426	0.0087	CbGeAlD
Olanzapine—HTR2A—respiratory system—lung cancer	0.000425	0.00869	CbGeAlD
Olanzapine—CHRM1—lung—lung cancer	0.000425	0.00869	CbGeAlD
Olanzapine—HTR2B—lung—lung cancer	0.000423	0.00864	CbGeAlD
Olanzapine—ADRA2A—bronchus—lung cancer	0.000412	0.00842	CbGeAlD
Olanzapine—H1F0—lymph node—lung cancer	0.000401	0.0082	CbGeAlD
Olanzapine—HRH1—trachea—lung cancer	0.000376	0.00769	CbGeAlD
Olanzapine—ADRA2A—trachea—lung cancer	0.00037	0.00756	CbGeAlD
Olanzapine—HTR7—lung—lung cancer	0.000362	0.0074	CbGeAlD
Olanzapine—HTR2A—epithelium—lung cancer	0.000356	0.00727	CbGeAlD
Olanzapine—ADRA2A—cardiac atrium—lung cancer	0.000347	0.0071	CbGeAlD
Olanzapine—ORM1—lymph node—lung cancer	0.000343	0.007	CbGeAlD
Olanzapine—DRD2—lung—lung cancer	0.000342	0.007	CbGeAlD
Olanzapine—ADRA2C—lung—lung cancer	0.000333	0.0068	CbGeAlD
Olanzapine—HTR2A—trachea—lung cancer	0.000314	0.00642	CbGeAlD
Olanzapine—ALB—lymph node—lung cancer	0.0003	0.00614	CbGeAlD
Olanzapine—HTR2B—lymph node—lung cancer	0.000289	0.00591	CbGeAlD
Olanzapine—CYP1A2—lung—lung cancer	0.000289	0.0059	CbGeAlD
Olanzapine—ABCB1—respiratory system—lung cancer	0.000279	0.0057	CbGeAlD
Olanzapine—HRH1—lung—lung cancer	0.00027	0.00553	CbGeAlD
Olanzapine—ADRA2A—lung—lung cancer	0.000266	0.00543	CbGeAlD
Olanzapine—ABCB1—epithelium—lung cancer	0.000233	0.00476	CbGeAlD
Olanzapine—ADRA2C—lymph node—lung cancer	0.000228	0.00465	CbGeAlD
Olanzapine—HTR2A—lung—lung cancer	0.000226	0.00462	CbGeAlD
Olanzapine—ABCB1—trachea—lung cancer	0.000206	0.00421	CbGeAlD
Olanzapine—HRH1—lymph node—lung cancer	0.000185	0.00378	CbGeAlD
Olanzapine—ADRA2A—lymph node—lung cancer	0.000182	0.00371	CbGeAlD
Olanzapine—ABCB1—bone marrow—lung cancer	0.000163	0.00334	CbGeAlD
Olanzapine—ABCB1—lung—lung cancer	0.000148	0.00303	CbGeAlD
Olanzapine—Clozapine—CYP2A6—lung cancer	0.000105	0.311	CrCbGaD
Olanzapine—ABCB1—lymph node—lung cancer	0.000101	0.00207	CbGeAlD
Olanzapine—Clozapine—CYP2E1—lung cancer	7.45e-05	0.221	CrCbGaD
Olanzapine—Clozapine—CYP1A1—lung cancer	7.35e-05	0.218	CrCbGaD
Olanzapine—Quetiapine—ABCB1—lung cancer	4.54e-05	0.135	CrCbGaD
Olanzapine—Clozapine—ABCB1—lung cancer	3.91e-05	0.116	CrCbGaD
Olanzapine—HTR1A—Signaling Pathways—MYC—lung cancer	2.18e-06	1.32e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—AKT1—lung cancer	2.17e-06	1.31e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MAPK3—lung cancer	2.17e-06	1.31e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MYC—lung cancer	2.17e-06	1.31e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	2.17e-06	1.31e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—TYMS—lung cancer	2.16e-06	1.31e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EP300—lung cancer	2.16e-06	1.3e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EP300—lung cancer	2.16e-06	1.3e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.16e-06	1.3e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—PIK3CA—lung cancer	2.15e-06	1.3e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IL6—lung cancer	2.15e-06	1.3e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EP300—lung cancer	2.15e-06	1.3e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EP300—lung cancer	2.15e-06	1.29e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—PIK3CA—lung cancer	2.14e-06	1.29e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GSTM1—lung cancer	2.14e-06	1.29e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CCND1—lung cancer	2.14e-06	1.29e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—SRC—lung cancer	2.14e-06	1.29e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	2.14e-06	1.29e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CD—lung cancer	2.14e-06	1.29e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EGFR—lung cancer	2.13e-06	1.29e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—JUN—lung cancer	2.13e-06	1.29e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—PIK3CA—lung cancer	2.13e-06	1.28e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EP300—lung cancer	2.12e-06	1.28e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EGFR—lung cancer	2.12e-06	1.28e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IL6—lung cancer	2.12e-06	1.28e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EP300—lung cancer	2.12e-06	1.28e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CD—lung cancer	2.12e-06	1.28e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—HRAS—lung cancer	2.11e-06	1.27e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MYC—lung cancer	2.11e-06	1.27e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—ALB—lung cancer	2.11e-06	1.27e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—SRC—lung cancer	2.1e-06	1.27e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—SRC—lung cancer	2.1e-06	1.27e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—SRC—lung cancer	2.09e-06	1.26e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—HRAS—lung cancer	2.09e-06	1.26e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IL6—lung cancer	2.09e-06	1.26e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—ALB—lung cancer	2.09e-06	1.26e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—KRAS—lung cancer	2.09e-06	1.26e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—SRC—lung cancer	2.09e-06	1.26e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TP53—lung cancer	2.08e-06	1.26e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VEGFA—lung cancer	2.08e-06	1.26e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MYC—lung cancer	2.08e-06	1.25e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MMP9—lung cancer	2.08e-06	1.25e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	2.07e-06	1.25e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—SRC—lung cancer	2.07e-06	1.25e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EGFR—lung cancer	2.07e-06	1.25e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PTEN—lung cancer	2.06e-06	1.24e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—STAT3—lung cancer	2.06e-06	1.24e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—SRC—lung cancer	2.06e-06	1.24e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CG—lung cancer	2.06e-06	1.24e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—NRAS—lung cancer	2.06e-06	1.24e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TP53—lung cancer	2.06e-06	1.24e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VEGFA—lung cancer	2.05e-06	1.24e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VEGFA—lung cancer	2.04e-06	1.23e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—AKT1—lung cancer	2.04e-06	1.23e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—AKT1—lung cancer	2.04e-06	1.23e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VEGFA—lung cancer	2.04e-06	1.23e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EGFR—lung cancer	2.03e-06	1.23e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VEGFA—lung cancer	2.03e-06	1.23e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—AKT1—lung cancer	2.03e-06	1.22e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—STAT3—lung cancer	2.03e-06	1.22e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CYP1A1—lung cancer	2.03e-06	1.22e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—STAT3—lung cancer	2.02e-06	1.22e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—NRAS—lung cancer	2.02e-06	1.22e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CB—lung cancer	2.02e-06	1.22e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IL6—lung cancer	2.02e-06	1.22e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—NRAS—lung cancer	2.02e-06	1.22e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—STAT3—lung cancer	2.02e-06	1.22e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—KRAS—lung cancer	2.02e-06	1.22e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	2.01e-06	1.21e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—NRAS—lung cancer	2.01e-06	1.21e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VEGFA—lung cancer	2.01e-06	1.21e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—STAT3—lung cancer	2.01e-06	1.21e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ERCC2—lung cancer	2.01e-06	1.21e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—NRAS—lung cancer	2.01e-06	1.21e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	2.01e-06	1.21e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—KRAS—lung cancer	2.01e-06	1.21e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTGS2—lung cancer	2.01e-06	1.21e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IL6—lung cancer	2e-06	1.21e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—HRAS—lung cancer	1.99e-06	1.2e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—STAT3—lung cancer	1.99e-06	1.2e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—NRAS—lung cancer	1.99e-06	1.2e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—STAT3—lung cancer	1.99e-06	1.2e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—AKT1—lung cancer	1.99e-06	1.2e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—NRAS—lung cancer	1.98e-06	1.2e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CB—lung cancer	1.98e-06	1.19e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MAPK3—lung cancer	1.97e-06	1.19e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EP300—lung cancer	1.97e-06	1.19e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—HRAS—lung cancer	1.97e-06	1.19e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—POMC—lung cancer	1.96e-06	1.18e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTGS2—lung cancer	1.96e-06	1.18e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—AKT1—lung cancer	1.96e-06	1.18e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—KRAS—lung cancer	1.95e-06	1.18e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTEN—lung cancer	1.95e-06	1.17e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MAPK3—lung cancer	1.94e-06	1.17e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MAPK3—lung cancer	1.93e-06	1.17e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—AKT1—lung cancer	1.93e-06	1.16e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MAPK3—lung cancer	1.93e-06	1.16e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MAPK3—lung cancer	1.92e-06	1.16e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—KRAS—lung cancer	1.92e-06	1.16e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—PIK3CA—lung cancer	1.92e-06	1.16e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MYC—lung cancer	1.92e-06	1.16e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—SRC—lung cancer	1.91e-06	1.15e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CREBBP—lung cancer	1.91e-06	1.15e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IL6—lung cancer	1.91e-06	1.15e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MAPK3—lung cancer	1.9e-06	1.15e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	1.9e-06	1.14e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—PIK3CA—lung cancer	1.9e-06	1.14e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MYC—lung cancer	1.89e-06	1.14e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IL6—lung cancer	1.88e-06	1.14e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MYC—lung cancer	1.88e-06	1.13e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MYC—lung cancer	1.88e-06	1.13e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EGFR—lung cancer	1.87e-06	1.13e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MYC—lung cancer	1.87e-06	1.13e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—AKT1—lung cancer	1.87e-06	1.13e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	1.86e-06	1.12e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CB—lung cancer	1.86e-06	1.12e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—EP300—lung cancer	1.86e-06	1.12e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TP53—lung cancer	1.86e-06	1.12e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—PIK3CA—lung cancer	1.85e-06	1.12e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MYC—lung cancer	1.85e-06	1.12e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—AKT1—lung cancer	1.85e-06	1.11e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MYC—lung cancer	1.85e-06	1.11e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—STAT3—lung cancer	1.85e-06	1.11e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CB—lung cancer	1.85e-06	1.11e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTGS2—lung cancer	1.84e-06	1.11e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EGFR—lung cancer	1.84e-06	1.11e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	1.84e-06	1.11e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NRAS—lung cancer	1.84e-06	1.11e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EGFR—lung cancer	1.84e-06	1.11e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EGFR—lung cancer	1.83e-06	1.11e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTGS2—lung cancer	1.83e-06	1.1e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EGFR—lung cancer	1.83e-06	1.1e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EGFR—lung cancer	1.81e-06	1.09e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CD—lung cancer	1.81e-06	1.09e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EGFR—lung cancer	1.81e-06	1.09e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—PIK3CA—lung cancer	1.79e-06	1.08e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TP53—lung cancer	1.79e-06	1.08e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ALB—lung cancer	1.79e-06	1.08e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TP53—lung cancer	1.78e-06	1.08e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—HRAS—lung cancer	1.78e-06	1.07e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—KRAS—lung cancer	1.77e-06	1.07e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	1.76e-06	1.06e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	1.76e-06	1.06e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—AKT1—lung cancer	1.76e-06	1.06e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—AKT1—lung cancer	1.75e-06	1.06e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTEN—lung cancer	1.75e-06	1.05e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—KRAS—lung cancer	1.74e-06	1.05e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PIK3CA—lung cancer	1.74e-06	1.05e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—APOA1—lung cancer	1.74e-06	1.05e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—KRAS—lung cancer	1.74e-06	1.05e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—AKT1—lung cancer	1.74e-06	1.05e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TP53—lung cancer	1.73e-06	1.05e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—KRAS—lung cancer	1.73e-06	1.05e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—KRAS—lung cancer	1.73e-06	1.04e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MYC—lung cancer	1.72e-06	1.03e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—HRAS—lung cancer	1.71e-06	1.03e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—KRAS—lung cancer	1.71e-06	1.03e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTEN—lung cancer	1.71e-06	1.03e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TP53—lung cancer	1.71e-06	1.03e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—KRAS—lung cancer	1.71e-06	1.03e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—HRAS—lung cancer	1.71e-06	1.03e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IL6—lung cancer	1.7e-06	1.02e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EGFR—lung cancer	1.68e-06	1.01e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—EP300—lung cancer	1.67e-06	1.01e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—HRAS—lung cancer	1.66e-06	1e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IL6—lung cancer	1.64e-06	9.89e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—HRAS—lung cancer	1.63e-06	9.84e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IL6—lung cancer	1.63e-06	9.84e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—EP300—lung cancer	1.63e-06	9.82e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—PIK3CA—lung cancer	1.63e-06	9.81e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTEN—lung cancer	1.61e-06	9.7e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PIK3CA—lung cancer	1.6e-06	9.65e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PIK3CA—lung cancer	1.6e-06	9.63e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTEN—lung cancer	1.59e-06	9.62e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PIK3CA—lung cancer	1.59e-06	9.6e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CG—lung cancer	1.59e-06	9.58e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IL6—lung cancer	1.59e-06	9.57e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PIK3CA—lung cancer	1.59e-06	9.57e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—KRAS—lung cancer	1.59e-06	9.56e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CB—lung cancer	1.58e-06	9.51e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TP53—lung cancer	1.57e-06	9.49e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	1.57e-06	9.48e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—AKT1—lung cancer	1.57e-06	9.46e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	1.57e-06	9.45e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTGS2—lung cancer	1.56e-06	9.42e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL6—lung cancer	1.56e-06	9.42e-06	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—AKT1—lung cancer	1.55e-06	9.35e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TP53—lung cancer	1.55e-06	9.34e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TP53—lung cancer	1.55e-06	9.32e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TP53—lung cancer	1.54e-06	9.29e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TP53—lung cancer	1.54e-06	9.26e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—EP300—lung cancer	1.53e-06	9.25e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—EP300—lung cancer	1.52e-06	9.17e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TP53—lung cancer	1.52e-06	9.17e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TP53—lung cancer	1.52e-06	9.14e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—AKT1—lung cancer	1.51e-06	9.13e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—POMC—lung cancer	1.51e-06	9.12e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—AKT1—lung cancer	1.51e-06	9.08e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—HRAS—lung cancer	1.51e-06	9.08e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—HRAS—lung cancer	1.48e-06	8.93e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—HRAS—lung cancer	1.48e-06	8.91e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—HRAS—lung cancer	1.47e-06	8.88e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CREBBP—lung cancer	1.47e-06	8.88e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—HRAS—lung cancer	1.47e-06	8.85e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—AKT1—lung cancer	1.46e-06	8.83e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	1.46e-06	8.78e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—HRAS—lung cancer	1.45e-06	8.77e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—HRAS—lung cancer	1.45e-06	8.74e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—AKT1—lung cancer	1.44e-06	8.69e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL6—lung cancer	1.44e-06	8.69e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—AKT1—lung cancer	1.42e-06	8.58e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL6—lung cancer	1.42e-06	8.55e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL6—lung cancer	1.41e-06	8.53e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL6—lung cancer	1.41e-06	8.5e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TP53—lung cancer	1.41e-06	8.5e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL6—lung cancer	1.41e-06	8.47e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CD—lung cancer	1.4e-06	8.42e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL6—lung cancer	1.39e-06	8.39e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL6—lung cancer	1.39e-06	8.37e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ALB—lung cancer	1.38e-06	8.31e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PIK3CA—lung cancer	1.37e-06	8.29e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTEN—lung cancer	1.36e-06	8.22e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—HRAS—lung cancer	1.35e-06	8.12e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—AKT1—lung cancer	1.33e-06	8.01e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—AKT1—lung cancer	1.31e-06	7.89e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—AKT1—lung cancer	1.3e-06	7.87e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—AKT1—lung cancer	1.3e-06	7.84e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—EP300—lung cancer	1.3e-06	7.84e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—AKT1—lung cancer	1.3e-06	7.82e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL6—lung cancer	1.29e-06	7.78e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—AKT1—lung cancer	1.28e-06	7.74e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—AKT1—lung cancer	1.28e-06	7.72e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CA—lung cancer	1.23e-06	7.44e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CB—lung cancer	1.22e-06	7.34e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTGS2—lung cancer	1.21e-06	7.27e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CA—lung cancer	1.2e-06	7.26e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—AKT1—lung cancer	1.19e-06	7.17e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CA—lung cancer	1.13e-06	6.84e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CA—lung cancer	1.13e-06	6.78e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—AKT1—lung cancer	1.12e-06	6.77e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTEN—lung cancer	1.05e-06	6.34e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—AKT1—lung cancer	1.01e-06	6.08e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—EP300—lung cancer	1e-06	6.05e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—AKT1—lung cancer	9.84e-07	5.93e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CA—lung cancer	9.61e-07	5.8e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—AKT1—lung cancer	9.27e-07	5.59e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—AKT1—lung cancer	9.19e-07	5.54e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AKT1—lung cancer	7.85e-07	4.74e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CA—lung cancer	7.42e-07	4.47e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AKT1—lung cancer	6.06e-07	3.66e-06	CbGpPWpGaD
